Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
---|
09/18/2003 | WO2003075929A1 Inhibitors of histone deacetylase |
09/18/2003 | WO2003075857A2 Amino-methyl substituted tetracycline compounds |
09/18/2003 | WO2003053915A3 Compounds for the treatment of inflammatory disorders |
09/18/2003 | WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
09/18/2003 | US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
09/18/2003 | US20030176495 HIV Integrase inhibitors |
09/18/2003 | US20030176485 Calcium receptor active compounds |
09/18/2003 | US20030176478 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease |
09/18/2003 | US20030176446 2,2-disubstituted 1,3-dioxolanes as antitussive agents |
09/18/2003 | US20030176440 For protecting skeletal muscles against damage resulting from trauma, protecting skeletal muscles subsequent to muscle or systemic diseases, therapy of shock conditions, preserving donor tissue and organs used in transplants |
09/18/2003 | US20030175995 Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
09/18/2003 | US20030175943 Biosynthesis of antitumor agents |
09/18/2003 | US20030172470 Intense, stable blue color shades can be obtained in addition to natural and purple or violet shades. |
09/18/2003 | CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents |
09/17/2003 | EP1344109A2 Onium salts and the use therof as latent acids |
09/17/2003 | EP1343493A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
09/17/2003 | EP1021426B1 Catalytic asymmetric epoxidation |
09/17/2003 | EP0970066B1 Preparation of aminoepoxides from aminoaldehydes and an in situ formed halomethyl organometallic reagent |
09/17/2003 | CN1443179A Aniline derivatives |
09/17/2003 | CN1442415A Preparation method of iso propylidene shikimic acid and its new use |
09/17/2003 | CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities |
09/17/2003 | CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors |
09/16/2003 | US6620950 Starting from various bicyclo(5.3.1)undec-10-ene compounds of given formula having protected hydroxyl groups; use as antitumor agents |
09/12/2003 | WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors |
09/12/2003 | WO2002053518A3 HALOGENATED-α,β-UNSATURATED-β-(SUBSTITUTED-AMINO) CARBOXYLATE ESTERS |
09/11/2003 | US20030171585 Anti-inflammatory compounds |
09/11/2003 | US20030171570 Acetal phosphoramidites for linking with a nucleotide sequence, converting the acetal group to aldehyde, for conjugating biomolecules; acetalization, oxidation |
09/11/2003 | US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
09/11/2003 | US20030170381 Piezoelectric element and process for production thereof |
09/10/2003 | EP1341746A1 Liquid crystalline compounds |
09/10/2003 | EP1341742A1 Method for producing compounds having a cf2o bridge |
09/10/2003 | EP1159237B1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
09/10/2003 | EP0939627B1 Pentafluorobenzenesulfonamides and analogs |
09/10/2003 | EP0896533B1 Pentafluorobenzenesulfonamides and analogs |
09/10/2003 | CN1441805A Antitumoral analogue of Et-743 |
09/10/2003 | CN1441797A Chiral compounds Ôàó" |
09/10/2003 | CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors |
09/09/2003 | US6617322 Administering a piperazine or piperidine coupled through a linker to a benzhydril |
09/04/2003 | WO2003072535A2 Substituted hydroxyethylamines |
09/04/2003 | WO2003016298A3 Process for making a compound containing cyclic and linear carbonate groups |
09/04/2003 | US20030166963 Using tertiary amine catalyst |
09/04/2003 | US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases |
09/04/2003 | US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents |
09/04/2003 | US20030165532 Extracts from the fungus Guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus Gignardia sp. and its use in pharmaceutical compositions |
09/04/2003 | CA2477607A1 Substituted hydroxyethylamines |
09/03/2003 | EP1340981A2 Antibodies for detecting amphetamine derivatives |
09/03/2003 | EP1339673A1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
09/03/2003 | EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
09/03/2003 | CN1440414A Synthesis of cuttlefish compound |
09/02/2003 | US6613942 Glucagon antagonists/inverse agonists |
09/02/2003 | US6613805 For therapy and prophylaxis of neurodegenerative diseases such as Alzheimer's disease, Down's syndrome, Parkinson's disease, Creutzfeldt-Jacob disease, amyotrophic sclerosis on lateral fasciculus, multiple sclerosis, and neurological disorders |
09/02/2003 | US6613803 Treating, preventing or ameliorating pain |
08/28/2003 | WO2003070714A1 Fluorous acetylation |
08/28/2003 | WO2003070692A1 Novel propionic acid derivative |
08/28/2003 | WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
08/28/2003 | US20030162817 Pentafluorobenzenesulfonamides and analogs |
08/28/2003 | US20030162778 Carbocyclic side chain containing metalloprotease inhibitors |
08/28/2003 | US20030162282 Such as 2-(t-butyldimethylsilyloxymethyl)-3,4-((dimethylmethylene)-dioxy)-5-hydroxy -tricyclo(5.2.1.02,6) deca-3,8-diene; for Diels-Alder reaction; antitumor agents |
08/28/2003 | US20030162281 Intermediates and improved processes for the preparation of neplanocin A |
08/28/2003 | CA2477205A1 Novel propionic acid derivative |
08/27/2003 | EP0926147B1 Process for preparing 1,3-dioxolane-4-methanol compounds |
08/27/2003 | EP0901469B1 Arylalkylpiperazine compounds as antioxidants |
08/27/2003 | EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
08/27/2003 | EP0846111B1 Syntheses of optically pure compounds useful as garft inhibitors and their intermediates |
08/27/2003 | CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
08/27/2003 | CN1119342C Process for preparing bromo-ortho-piperonaldehyde |
08/27/2003 | CN1119341C Method for the continuous production of 1,3-dioxolan-2-ones |
08/27/2003 | CN1119338C Alpha-(1-piperazinyl) ocetamido arenecarboxylic aicd derivatives as antidiabetic agents |
08/27/2003 | CN1119310C Cyclo pentane-1,3-dione derivatives |
08/26/2003 | US6610892 Process for preparing 2,7-dimethyl-2,4,6-octatrienal monoacetals |
08/26/2003 | US6610482 Sequencing, fingerprinting and mapping biological macromolecules, typically biological polymers. The methods make use of a plurality of sequence specific recognition reagents which can also be used for classification of |
08/21/2003 | WO2003069350A2 Small molecule modulators of apoptosis |
08/21/2003 | WO2002032844A8 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives |
08/21/2003 | US20030158427 Using Wittig or Wittig-Horner reaction; use in selective synthesis of various C40 carotenoids |
08/21/2003 | US20030158259 Drugs for treating obesity and diabetes and animal feed additives |
08/21/2003 | US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa. |
08/21/2003 | US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
08/21/2003 | US20030157697 Intermediates and improved processes for the preparation of neplanocin A |
08/20/2003 | EP1336600A2 Dimer-selective RXR modulators and methods for their use |
08/20/2003 | EP1335899A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
08/20/2003 | EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
08/20/2003 | EP1150944B1 N2-phenylamidine derivatives |
08/20/2003 | EP0776330B1 Photolabile compounds and methods for their use |
08/20/2003 | CN1437578A (P-amino-hyaroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
08/20/2003 | CN1118448C Process for producing benzyl-ethers |
08/19/2003 | US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders |
08/19/2003 | US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
08/19/2003 | US6608061 Bisaryl compound and medicament for cancer treatment comprising the same |
08/19/2003 | CA2043733C Aromatic compounds |
08/14/2003 | WO2003066889A2 Assay for acytyltransferase or deacetylase activity |
08/14/2003 | WO2003066581A1 Urea linker derivatives for use as ppar modulators |
08/14/2003 | WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
08/14/2003 | WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto |
08/14/2003 | WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
08/14/2003 | US20030153788 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents |
08/14/2003 | US20030153706 5- or 6-membered ring acetal structure is connected to a norbornene structure through a linker represented by -(CH2)m-m=1 to 8 used as monomer; polymer is sensitive to high energy radiation excellent resolution, and etching resistance |
08/14/2003 | US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
08/14/2003 | US20030153579 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
08/14/2003 | US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists |
08/14/2003 | US20030153544 Fatty acid derivatives |